A targeted drug has shown promising activity against brain metastases resulting from kidney cancer, achieving a 50 percent response rate, and supporting further studies of the drug in this patient group whose poor prognosis ...
Oct 21, 2021
0
0
How cancers metastasize remains poorly understood. The process begins when cancer cells break off from a tumor and invade blood and lymphatic vessels, the body's alleyways. But studying invasion—typically a microscopic ...
Oct 20, 2021
0
61
DEAR MAYO CLINIC: I was recently diagnosed with breast cancer. The doctor mentioned using immunotherapy. What is immunotherapy, and how does it differ from chemotherapy, which I've traditionally heard about for treating cancer?
Oct 8, 2021
0
6
Venous thromboembolism (VTE) refers to blood clots in the veins, which is a serious yet preventable medical condition and is often seen with advanced cancers. Researchers at Rutgers Cancer Institute of New Jersey explored ...
Sep 13, 2021
0
2
Austin resident Betty Williams, 82, lost her big toe on her right foot to diabetes.
Jul 30, 2021
0
148
A study led by Keele University aims to improve outcomes for pregnant women who are at a higher risk of complications due to a current or historical cancer diagnosis.
Jul 14, 2021
0
1
Using an existing drug for late-stage kidney cancer at an earlier stage of the disease could reduce the risk of cancer recurring by a third, according to new research.
Jul 11, 2021
0
3
In recent years, cancer immunotherapy has been effective in treating patients with immunogenic, or so-called "hot" tumors with increased levels of inflammation and the presence of immune cells in and around the tumors. Prostate ...
Jun 24, 2021
0
4
The immune nature of kidney cancer stands out when compared to other cancers: More immune cells infiltrate kidney cancers than most other solid tumors, and kidney cancer is one of the most responsive malignancies to today's ...
May 20, 2021
0
9
A new cancer vaccine could boost the positive effects of existing immunotherapy drugs, improving the success rate of treatments from 20% to 75% of cases, according to a new study by immunologists from the University of Konstanz. ...
May 18, 2021
0
218
